Download by
Scanning QR Code
智通财经APP讯，力高健康生活(02370)公布，有关全球发售的稳定价格期间已于2022年4月24日(即递交香港公开发售申请截止日期后第30日)结束。
Zhitong Financial APP News, Rico Health Life (02370) announced that the stable price period for the global offering ended on April 24, 2022 (that is, the 30th day after the deadline for submitting applications for Hong Kong public offerings).
由于国际发售的股份概无超额配发，因此独家代表人(为其本身及代表包销商)不会行使超额配股权且稳定价格操作人或任何为其行事的人士于稳定价格期间概无进行有关全球发售的任何稳定价格行动。
As there is no over-allotment of the shares on the international offer, therefore, the sole representative (for himself and on behalf of the underwriter) will not exercise the over-allotment option and the price stabilization operator or any person acting for him has not carried out any stable price action in relation to the global offer during the period of price stabilization.
超额配股权于2022年4月24日(即递交香港公开发售申请截止日期后第 30 日)失效。因此，概无根据超额配股权发行或将会发行股份。
The over-allotment option will expire on April 24, 2022, that is, the 30th day after the deadline for submitting applications for the Hong Kong public offering. Therefore, no shares are issued or will be issued under the over-allotment option.
董事确认，公司将继续符合上市规则第8.08(1)(a)条的公众持股量规定，即无论何时，公司已发行股份数目总额必须至少有25%由公众人士持有。
The directors confirm that the company will continue to comply with the public shareholding requirement under rule 8.08 (1) (a) of the listing rules, that is, at all times, at least 25% of the total number of shares issued by the company must be held by the public.